Hält derzeit Positionen bei CRISPR Therapeutics AG, Genocea Biosciences Inc and Adaptimmune Therapeutics PLC
Position | Company | Period |
---|---|---|
Independent Director | CRISPR Therapeutics AG | 1. April 2015 - |
Independent Director | Genocea Biosciences Inc | 8. Februar 2018 - |
Non-Executive Independent Director | Adaptimmune Therapeutics PLC | 1. September 2014 - |
Independent Director | Nevro Corp | 1. September 2014 - 19. März 2019 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-07-19 | 2023-07-17 |
Savara Inc
(SVRA)
|
K Kauf |
333.333
+1.4%
3,00999.999 USD |
333.333 +1.4% | 3,00 | 999.999 USD | |
2022-05-26 | 2022-05-25 |
Genocea Biosciences Inc
(GNCA)
|
V Verkauf |
4.445.093
-100.0%
0,08362.720 USD |
4.445.093 -100.0% | 0,08 | 362.720 USD | |
2022-05-26 | 2022-05-24 |
Genocea Biosciences Inc
(GNCA)
|
V Verkauf |
5.931.843
-57.2%
0,07387.943 USD |
5.931.843 -57.2% | 0,07 | 387.943 USD | |
2022-04-13 | 2022-04-11 |
Trevi Therapeutics Inc
(TRVI)
|
K Kauf |
948.948
+inf%
1,901.803.001 USD |
948.948 +inf% | 1,90 | 1.803.001 USD | |
2022-04-13 | 2022-04-11 |
Trevi Therapeutics Inc
(TRVI)
|
K Kauf |
2.631.578
+33.8%
1,904.999.998 USD |
2.631.578 +33.8% | 1,90 | 4.999.998 USD | |
2021-10-19 | 2021-10-18 |
Trevi Therapeutics Inc
(TRVI)
|
K Kauf |
1.851.852
0,000 USD |
1.851.852 | 0,00 | 0 USD | |
2021-03-18 | 2021-03-16 |
Marker Therapeutics Inc
(MRKR)
|
K Kauf |
5.714.285
+114.3%
1,759.999.999 USD |
5.714.285 +114.3% | 1,75 | 9.999.999 USD | |
2020-12-07 | 2020-12-04 |
Regulus Therapeutics Inc
(RGLS)
|
K Kauf |
4.398.602
+214.3%
0,622.735.930 USD |
4.398.602 +214.3% | 0,62 | 2.735.930 USD | |
2020-09-22 | 2020-09-18 |
Metacrine, Inc.
(MTCR)
|
K Kauf |
769.230
+33.6%
13,009.999.990 USD |
769.230 +33.6% | 13,00 | 9.999.990 USD | |
2020-07-28 | 2020-07-24 |
Genocea Biosciences Inc
(GNCA)
|
K Kauf |
3.151.260
+43.6%
2,257.090.335 USD |
3.151.260 +43.6% | 2,25 | 7.090.335 USD | |
2020-07-01 | 2020-06-30 |
Akouos Inc
(AKUS)
|
K Kauf |
588.235
+15.9%
17,009.999.995 USD |
588.235 +15.9% | 17,00 | 9.999.995 USD | |
2020-04-13 | 2020-04-03 |
Trevi Therapeutics Inc
(TRVI)
|
V Verkauf |
564
-0.0%
2,661.500 USD |
564 -0.0% | 2,66 | 1.500 USD | |
2020-02-05 | 2020-02-03 | K Kauf |
800.000
+30.2%
19,0015.200.000 USD |
800.000 +30.2% | 19,00 | 15.200.000 USD | ||
2020-01-28 | 2020-01-24 |
Adaptimmune Therapeutics PLC
(ADAP)
|
K Kauf |
7.500.000
+62.5%
0,675.000.250 USD |
7.500.000 +62.5% | 0,67 | 5.000.250 USD | |
2019-07-24 | 2019-07-22 |
Mirum Pharmaceuticals Inc
(MIRM)
|
K Kauf |
450.000
+12.0%
15,006.750.000 USD |
450.000 +12.0% | 15,00 | 6.750.000 USD | |
2019-06-25 | 2019-06-24 |
Genocea Biosciences Inc
(GNCA)
|
K Kauf |
2.857.142
+65.4%
3,509.999.997 USD |
2.857.142 +65.4% | 3,50 | 9.999.997 USD | |
2019-05-13 | 2019-05-09 |
Trevi Therapeutics Inc
(TRVI)
|
K Kauf |
1.500.000
+51.0%
10,0015.000.000 USD |
1.500.000 +51.0% | 10,00 | 15.000.000 USD | |
2019-05-13 | 2019-05-09 |
Trevi Therapeutics Inc
(TRVI)
|
K Kauf |
1.000.000
+51.6%
10,0010.000.000 USD |
1.000.000 +51.6% | 10,00 | 10.000.000 USD | |
2019-05-09 | 2019-05-07 |
Regulus Therapeutics Inc
(RGLS)
|
K Kauf |
1.136.704
+124.1%
1,081.227.640 USD |
1.136.704 +124.1% | 1,08 | 1.227.640 USD | |
2019-02-19 | 2019-02-14 |
Genocea Biosciences Inc
(GNCA)
|
K Kauf |
9.948.269
+39.8%
0,474.688.619 USD |
9.948.269 +39.8% | 0,47 | 4.688.619 USD |